The agency's review of data on the drug Onglyza, from AstraZeneca, also found an increased risk of hospitalization due to heart failure. [Source: Newsy Science]
Videos
APR 13, 2015
FDA Cites Diabetes Drug For Possible Increased Risk Of Death
The agency's review of data on the drug Onglyza, from AstraZeneca, also found an increased risk of hospitalization due to heart failure. [Source: Newsy Science]